In particular, this polymorphism in RGS6 was associated with a 34% reduction in bladder cancer incidence with stratified analyses revealing a 40% and 58% cancer reduction in smokers and in those who began smoking at young age, respectively [20]. This evidence concerns the gene RGS6 and cancer.